Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.30B.
ENTERPRISE VALUE (EV)
$2.30B
Liquidia Corporation
Market Cap
$2.30B
Enterprise Value (EV)
$2.30B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Liquidia Corporation (LQDA) | $2.30B | $2.30B |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | $1.88B |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | $2.47B |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | $2.34B |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | $2.43B |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | $2.33B |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | $2.15B |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | $2.19B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | $1.95B |
| Pharvaris N.V. (PHVS)vs › | $2.17B | $1.81B |
Market Cap
$2.30B
Total Debt
$191.34M
Cash
$190.68M
Enterprise Value
$2.30B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
